Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
An open label, Phase Ia/Ib dose finding study with BI 894999 orally administered once a day in patients with advanced malignancies with repeated administration in patients with clinical benefit
Protocol ID
1367.1
Disease (Sub Disease)
Non malignant Skin Cancer
Kidney Cancer
Diagnosis Stage
New Diagnosis
Relapse/Refractory
Location
NSW
Sponsor
Boehringer Ingelheim
Trial Status
Open
Sites
Sydney Children's Hospital
Study Type
Treatment
Phase
Phase 1
Age Eligibility
18 Years and older
International registry ID's
NCT02516553
Back to Registry
Study Title An open label Phase Ia/Ib dose finding study with BI 894999 orally administered once a day in patients with advanced malignancies with repeated administration in patients with clinical benefit
Protocol ID 1367.1
Disease (Sub Disease) Non malignant Skin Cancer
Kidney Cancer
Diagnosis Stage New Diagnosis
Relapse/Refractory
Location NSW
Sponsor Boehringer Ingelheim
Links https://clinicaltrials.gov/ct2/show/NCT02516553
Trial Status Open
Trial Open Date 09/12/2020
Sites Sydney Children's Hospital
Study Type Treatment
Phase Phase 1
Age Eligibility 18 Years and older
International registry ID's NCT02516553